Dermatan Sulfate Concept

Vocabulary Service

MeSH

Overview

subject area of

A Low Molecular Weight Heparin Alters the Fetal Coagulation System in the Pregnant Sheep Journal Articles
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke Journal Articles
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Journal Articles
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. Journal Articles
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Journal Articles
Comparison of Heparin- and Dermatan Sulfate-mediated Catalysis of Thrombin Inactivation by Heparin Cofactor II Journal Articles
Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate Complexes Journal Articles
Current agents for the treatment of patients with heparin-induced thrombocytopenia Journal Articles
DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE Journal Articles
Dermatan sulphate in heparin-induced thrombocytopenia Journal Articles
Effect of Covalent Serpin–Heparinoid Complexes on Plasma Thrombin Generation on Fetal Distal Lung Epithelium Journal Articles
Effect of Dermatan Sulphate on Activated Partial Thromboplastin Time Determined with Different Reagents Journal Articles
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Journal Articles
Effects of Dermatan Sulfate and Heparin on Inhibition of Thrombus Growth in Vivo Journal Articles
Effects of Sulfated Polysaccharides on Inhibition of Thrombus Formation initiated by Different Stimuli Journal Articles
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbitsa Journal Articles
Evidence for thrombin binding to dermatan sulphate sites in the rabbit aorta subendothelium in vitro Journal Articles
Extraction and analysis of glycosaminoglycans from intima-media of single rabbit aortae: effect of balloon catheter de-endothelialization on the content and profile of glycosaminoglycans Journal Articles
Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Journal Articles
Glycosaminoglycans Bind Factor Xa in a Ca²⁺-Dependent Fashion and Modulate Its Catalytic Activity Journal Articles
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect Journal Articles
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways Journal Articles
Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Journal Articles
Heparin Cofactor II and Other Endogenous Factors in the Mediation of the Antithrombotic and Anticoagulant Effects of Heparin and Dermatan Sulfate Journal Articles
Heparin-Induced Thrombocytopenia: A Ten-Year Retrospective Journal Articles
Heparin-induced thrombocytopenia and its treatment. Conferences
Heparin-induced thrombocytopenia in intensive care patients Journal Articles
Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management^ Journal Articles
Heparin/Heparan Sulfate (HP/HS) Interacting Protein (HIP) Supports Cell Attachment and Selective, High Affinity Binding of HP/HS Journal Articles
Heparin‐induced thrombocytopenia – therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4–heparin complexes Journal Articles
In vivo activity of a new heparinoid Journal Articles
In vivo activity of a new heparinoid. Journal Articles
Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis Journal Articles
Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate Journal Articles
Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma Journal Articles
Is Heparin the Ideal Anticoagulant for Cardiopulmonary Bypass? Dermatan Sulphate May Be an Alternate Choice Journal Articles
Lack of Relationship Between Enhanced Bleeding Induced by Heparin and Other Sulfated Polysaccharides and Enhanced Catalysis of Thrombin Inhibition Journal Articles
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Journal Articles
Low molecular weight heparins and heparinoids Journal Articles
Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture Journal Articles
Mechanisms for Inhibition of the Generation of Thrombin Activity by Sulfated Polysaccharides^a Journal Articles
Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Journal Articles
Modulation of the Enzymatic Activity of α-Thrombin by Polyanions: Consequences on Intrinsic Activation of Factor V and Factor VIII Journal Articles
Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin Journal Articles
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Journal Articles
Orgaran in the Prevention of Deep Vein Thrombosis in Stroke Patients Journal Articles
Parenteral Anticoagulants Journal Articles
Parenteral Anticoagulants Journal Articles
Pharmacological Actions of Sulodexide Journal Articles
Plasma Anticoagulant Mechanisms of Heparin, Heparan Sulfate, and Dermatan Sulfatea Journal Articles
Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium. Journal Articles
Prophylaxis of Venous Thromboembolism in Stroke Patients Journal Articles
Rationale Behind the Development of Low Molecular Weight Heparin Derivatives Journal Articles
Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides Journal Articles
Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s Journal Articles
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Journal Articles
The haemorrhagic and antithrombotic effects of dermatan sulphate Journal Articles
The haemorrhagic and antithrombotic effects of dermatan sulphate. Journal Articles
The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate Journal Articles
The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin Journal Articles
Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa Journal Articles
Vasoflux, a New Anticoagulant With a Novel Mechanism of Action Journal Articles
Venous thromboembolism in heparin-induced thrombocytopenia Journal Articles